Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | KRRO | ORGO | ||
| Company | Akebia Therapeutics | Korro Bio Inc | Organogenesis Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.7700 | 42.86 | 3.06 | ||
| High | 1.8700 | 44.62 | 3.25 | ||
| Low | 1.7500 | 42.86 | 3.05 | ||
| Last | 1.8300 | 43.67 | 3.05 | ||
| Change | +0.0400 | +0.55 | -0.06 | ||
| % Change | +2.23% | +1.28% | -1.93% | ||
| Volume | 5,921,700 | 78,700 | 1,834,500 | ||
| 20-Day Average Volume | 2,350,265 | 132,050 | 1,064,320 | ||
| Previous Close | 1.7900 | 43.12 | 3.11 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.9475 | 47.44 | 3.65 | ||
| 20-Day Raw Stochastic | 20.93% | 34.64% | 0.00% | ||
| 20-Day Relative Strength | 49.91% | 44.40% | 40.74% | ||
| Weighted Alpha | +19.22 | -61.01 | -18.14 | ||
| Today's Opinion | 72% Buy | 56% Sell | 40% Buy | ||
| Previous Opinion | 72% Buy | 40% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 16% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.08% since 12/13/24 | -6.85% since 12/13/24 | -10.29% since 12/13/24 | ||
| Low | 1.7400 on 12/18/24 | 41.03 on 12/19/24 | 3.05 on 12/20/24 | ||
| High | 1.9000 on 12/18/24 | 52.00 on 12/18/24 | 3.68 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +2.23% since 11/20/24 | -7.09% since 11/20/24 | -23.17% since 11/20/24 | ||
| Low | 1.7400 on 12/18/24 | 36.77 on 12/05/24 | 3.05 on 12/20/24 | ||
| High | 2.1700 on 12/03/24 | 56.69 on 11/26/24 | 4.21 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | +33.58% since 09/20/24 | +20.20% since 09/20/24 | +7.77% since 09/20/24 | ||
| Low | 1.2400 on 10/01/24 | 30.72 on 10/04/24 | 2.73 on 09/23/24 | ||
| High | 2.1700 on 12/03/24 | 98.00 on 10/16/24 | 4.57 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +94.68% since 06/20/24 | +21.68% since 06/20/24 | +23.98% since 06/20/24 | ||
| Low | 0.8000 on 06/26/24 | 30.00 on 06/26/24 | 2.28 on 08/12/24 | ||
| High | 2.1700 on 12/03/24 | 98.00 on 10/16/24 | 4.57 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 399,271 | 409,114 | 383,464 | ||
| Shares Outstanding, K | 218,181 | 9,368 | 125,726 | ||
| Annual Sales | 194,620,000 | 0 | 433,140,000 | ||
| Annual Net Income | -51,930,000 | -81,170,000 | 4,950,000 | ||
| Last Quarter Sales | 37,430,000 | 0 | 115,180,000 | ||
| Last Quarter Net Income | -20,040,000 | -21,000,000 | 12,330,000 | ||
| 60-Month Beta | 0.70 | 1.98 | 1.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/07/24 | -2.26 on 11/12/24 | 0.09 on 11/12/24 | ||
| Latest Earnings Date | 11/07/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||